Cancer Metastasis, Cancer Immunology, Digital Pathology
Molecular and Precision Oncology, Cancer Immunology
Prognostic and Predictive BiomarkersSenescenceTumour Microenvironment
Team/Members of the group:
Molecular Pathology Research Lab, Cancer Metastasis Group, Prof. John O’Leary (PI), Dr Sharon O’Toole (PI), Bashir Mohamed (Postdoctoral fellow), Dr Mark Ward (Postdoctoral fellow), Tanya Kelly (Postdoctoral fellow)
Close Collaborators:
Prof. Doug Brooks, Dr Robert Brooks, Dr Stavros Selemedis, Dr Peter Caie, Prof. Tracy Robson, Dr Amanda McCann, Dr Fiona Furlong, Dr Britta Stordal
Main Funders:
SFI, HRB,
Additional Information:
Dr Mark Bates is a Cancer Biologist with a particular interest in mechanisms underlying resistance to chemotherapy and radiotherapy. Dr Bates has been involved in a number of projects in the breast, ovarian, cervical, oesophageal and prostate cancer space investigating novel markers associated with therapeutic resistance.